tabalumab
Term · Oncology and biomedicine · MLC-T-ONC-016955
A human IgG4 monoclonal antibody against B-cell activating factor (BAFF), with potential immunomodulating and antineoplastic activities. Tabalumab binds to and inhibits the activity of both soluble and cell surface-bound BAFF. This may reduce the activity, proliferation and survival of B-cells. A dysregulated expression of BAFF, a member of the tumor necrosis factor (TNF) family of proteins, is often seen in certain autoimmune diseases and certain cancers, and may promote B lymphocyte activation, proliferation and survival.
| Identifier | MLC-T-ONC-016955 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | anti-BAFF monoclonal antibody LY2127399 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-016955",
"term": "tabalumab",
"field": "Oncology and biomedicine",
"definition": "A human IgG4 monoclonal antibody against B-cell activating factor (BAFF), with potential immunomodulating and antineoplastic activities. Tabalumab binds to and inhibits the activity of both soluble and cell surface-bound BAFF. This may reduce the activity, proliferation and survival of B-cells. A dysregulated expression of BAFF, a member of the tumor necrosis factor (TNF) family of proteins, is often seen in certain autoimmune diseases and certain cancers, and may promote B lymphocyte activation, proliferation and survival.",
"synonyms": [
"anti-BAFF monoclonal antibody LY2127399"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/tabalumab/"
}
Record 15,925 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.